Bill Text: IN HB1360 | 2010 | Regular Session | Introduced
Bill Title: Vaccines containing thimerosal.
Spectrum: Partisan Bill (Republican 1-0)
Status: (Introduced - Dead) 2010-01-13 - First reading: referred to Committee on Public Health [HB1360 Detail]
Download: Indiana-2010-HB1360-Introduced.html
Citations Affected: IC 16-41-43; IC 25-1-9-6.6.
Synopsis: Vaccines containing thimerosal. Prohibits the
administration of influenza vaccines containing thimerosal to: (1)
children at least six months but less than 36 months of age; and (2)
pregnant women; unless no alternative vaccines are available or unless
there is an emergency. Requires the state department of health to
develop informational materials concerning trace amounts of mercury
in vaccines to give to individuals administering vaccines. Requires
individuals administering vaccines to give the materials to individuals
receiving vaccines. Provides that a health care practitioner may be
subject to disciplinary sanctions for failure to comply with these
requirements.
Effective: July 1, 2010.
January 13, 2010, read first time and referred to Committee on Public Health.
PRINTING CODE. Amendments: Whenever an existing statute (or a section of the Indiana Constitution) is being amended, the text of the existing provision will appear in this style type, additions will appear in this style type, and deletions will appear in
Additions: Whenever a new statutory provision is being enacted (or a new constitutional provision adopted), the text of the new provision will appear in this style type. Also, the word NEW will appear in that style type in the introductory clause of each SECTION that adds a new provision to the Indiana Code or the Indiana Constitution.
Conflict reconciliation: Text in a statute in this style type or
A BILL FOR AN ACT to amend the Indiana Code concerning
health.
Chapter 43. Administration of Vaccines
Sec. 1. Influenza vaccines administered to a child at least six (6) months of age but less than thirty-six (36) months of age or to a pregnant woman may not contain the preservative thimerosal. However, if:
(1) no alternative vaccines are available, vaccines with less than five-tenths (0.5) micrograms per five-tenths (0.5) milliliter dose of mercury may be administered; or
(2) there is an emergency, including:
(A) a supply disruption;
(B) a vaccine shortage; or
(C) an epidemic as determined by the state health commissioner;
vaccines with thimerosal may be administered.
Sec. 2. (a) The state department shall prepare information on the use of thimerosal and other preservatives in vaccines for health care providers to provide to:
(1) parents;
(2) guardians; or
(3) recipients of vaccines;
when administering vaccines.
(b) The information required in subsection (a) must include the following:
(1) Thimerosal:
(A) is a preservative used in vaccines; and
(B) contains forty-nine and six-tenths percent (49.6%) mercury.
(2) A brief history of the use of thimerosal in vaccines, including the request made in 1999 by the Academy of Pediatrics for the voluntary removal of thimerosal from vaccines.
(3) The availability of vaccines that do not contain thimerosal.
(4) Historical and factual information regarding thimerosal. This information must be updated periodically to include:
(A) recent developments in scientific knowledge;
(B) standards of health care practice; and
(C) legal requirements;
relevant to thimerosal.
(5) Other information that contributes to the ability of a patient, parent, or guardian to make an informed decision when choosing the type of vaccine to be administered.
(c) The state department shall study and determine the feasibility of requiring that all vaccines used in Indiana be free of thimerosal. The department shall submit a written report of its findings to the general assembly not later than October 1, 2010. The report to the general assembly must be in an electronic format under IC 5-14-6.
practitioner under IC 16-41-43 concerning the administration of vaccines.
